s-1
Small moleculeexperimental
S1, S01, S.I, S-1, S.1, Š-1 or S 1 may refer to: — Wikipedia
Clinical trial activity
226 trials · 150 clinical orgs · 0 marketing orgs
Phase 1
35
Phase 2
188
Phase 3
43
Phase 4
4
Earliest trial started May 1, 2000 (NCT00209638)
Timeline
Indications
Approved for
Studied for
- Adenocarcinoma · Phase 2
- Aged · Phase 2
- Anterior Cruciate Ligament Injuries · Phase 2
- Biliary Tract Neoplasms · Phase 3
- Breast Neoplasms · Phase 4
- Carcinoma · Phase 2
- Carcinoma, Hepatocellular · Phase 4
- Carcinoma, Non-Small-Cell Lung · Phase 2
- Carcinoma, Transitional Cell · Phase 2
- Chemoradiotherapy · Phase 3
- Chemoradiotherapy, Adjuvant · Phase 2
- Chemotherapy, Adjuvant · Phase 2
- Cholangiocarcinoma · Phase 3
- Colonic Neoplasms · Phase 2
- Colorectal Neoplasms · Phase 3
- Digestive System Neoplasms · Phase 1
- Drug-Related Side Effects and Adverse Reactions · Phase 2/Phase 3
- Drugs, Investigational · Phase 2
- Drug Therapy · Phase 2
- Esophageal Neoplasms · Phase 3
- Esophageal Squamous Cell Carcinoma · Phase 2
- Gastrointestinal Neoplasms · Phase 2
- General Surgery · Phase 2/Phase 3
- Head and Neck Neoplasms · Phase 2
- Immunotherapy · Phase 2
- Kidney Failure, Chronic · Phase 1
- Liver Diseases · Phase 2
- Malaria · Phase 3
- Nasopharyngeal Carcinoma · Phase 2
- Neoadjuvant Therapy · Phase 4
- Neoplasm Metastasis · Phase 3
- Neoplasms · Phase 2
- Oxaliplatin · Phase 2
- Pancreatic Neoplasms · Phase 4
- Peritoneal Neoplasms · Phase 2
- Pharmacological and Toxicological Phenomena · Phase 2
- Radiotherapy · Phase 2/Phase 3
- Radiotherapy, Intensity-Modulated · Phase 2
- Rectal Neoplasms · Phase 2
- Small Cell Lung Carcinoma · Phase 2
- Squamous Cell Carcinoma of Head and Neck · Phase 2
- Stomach Neoplasms · Phase 3
- Uterine Cervical Neoplasms · Phase 3
Mechanism of action
- Unspecified target
Combination
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06693128 | Phase 2 | Nov 20, 2024 | Chinese Academy of Medical Sciences, Jiao Tong University |
| NCT05218148 | Phase 2 | Apr 1, 2022 | Chinese Academy of Medical Sciences |
| NCT05144854 | Phase 3 | Dec 31, 2021 | Ono Pharmaceuticals |
| NCT05111444 | Phase 2 | Dec 31, 2021 | Fudan University |
| NCT05026905 | Phase 2 | Oct 1, 2021 | China Medical University, Government of Taiwan, Kaohsiung Medical University, National Cheng Kung University |
| NCT04982939 | Phase 2 | Jun 21, 2021 | Tianjin Medical University |
| NCT04217096 | Phase 4 | Jan 1, 2020 | Fudan University |
| NCT04208347 | Phase 2/Phase 3 (Phase 3) | Dec 31, 2019 | Jiao Tong University |
| NCT04207918 | Phase 2 | Nov 14, 2019 | Chinese Academy of Medical Sciences |
| NCT04070313 | Phase 2 | Jul 11, 2019 | Chang Gung University, National Cheng Kung University, National Taiwan University, Taipei Veteran General hospital, TTY Biopharm |
| NCT03986294 | Phase 2 | Jul 1, 2019 | Isala Clinics, Zwolle, The Netherlands, Maastricht University, Medical University of Vienna, University of Amsterdam, University of Verona, Utrecht University, Vall d'Hebron Institute of Research, Galatea Clinic |
| NCT03957564 | Phase 2 | May 20, 2019 | Qinghai University |
| NCT03885219 | Phase 2 | May 1, 2019 | Chinese Academy of Medical Sciences |
| NCT03843853 | Phase 2 | May 1, 2019 | Jiangsu Hansoh Pharmaceutical Co., Ltd., Nanjing Medical University |
| NCT03777462 | Phase 2 | Apr 1, 2019 | Changhai Hospital |
| NCT03878472 | Phase 2 | Apr 1, 2019 | Shandong University |
| NCT03850769 | Phase 2 | Mar 31, 2019 | Chinese Academy of Medical Sciences |
| NCT03801668 | Phase 3 | Mar 8, 2019 | Huazhong University of Science and Technology, Yiling Pharmaceutical Inc. |
| NCT03823118 | Phase 2 | Mar 1, 2019 | Wenzhou Medical University |
| NCT03779464 | Phase 2 | Mar 1, 2019 | Huazhong University of Science and Technology |
Showing 20 of 226 trials
Page 1 / 12
Organizations
Research & Development (150)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Otsuka | For profit | 34 | 22 | 3 | 2000 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 27 | 24 | 4 | 2009 |
| Fudan University | Academic/Hospital | 15 | 14 | 3 | 2010 |
| People's Liberation Army of China | Government | 13 | 12 | 3 | 2009 |
| Sun Yat-Sen University | Academic/Hospital | 12 | 12 | 2 | 2008 |
| National Cancer Center, Korea | Government | 11 | 7 | 3 | 2004 |
| Peking University | Academic/Hospital | 10 | 8 | 3 | 2005 |
| Zhejiang University | Academic/Hospital | 10 | 9 | 4 | 2010 |
| Hallym University | Academic/Hospital | 8 | 7 | 2 | 2005 |
| University of Ulsan | Academic/Hospital | 8 | 5 | 2 | 2004 |
| Hebei University | Academic/Hospital | 7 | 5 | 2 | 2009 |
| Seoul National University | Academic/Hospital | 7 | 4 | 2 | 2005 |
| Kansai Hepatobiliary Oncology Group (KHBO) | Academic/Hospital | 6 | 6 | 3 | 2010 |
| National Cheng Kung University | Academic/Hospital | 6 | 0 | 2 | 2009 |
| Sanofi | For profit | 6 | 4 | 3 | 2007 |
| Yonsei University | Academic/Hospital | 6 | 5 | 3 | 2008 |
| Chang Gung University | Academic/Hospital | 5 | 0 | 2 | 2008 |
| Chonnam National University | Academic/Hospital | 5 | 2 | 2 | 2008 |
| Fujian Medical University | Academic/Hospital | 5 | 3 | 3 | 2016 |
| IQVIA | For profit | 5 | 0 | 2 | 2005 |
150 organizations
Page 1 / 8